[Microanalysis of tryptophan metabolites]

Area of Science:

• Biochemistry
• Analytical Chemistry
• Oncology

Background:

• Tryptophan metabolites, including 3-hydroxykynurenine and 3-hydroxyanthranilic acid, are implicated in bladder cancer.
• The relationship between these metabolites and human bladder cancer warrants further investigation.

Purpose of the Study:

• To develop and validate sensitive fluorometric assays for key tryptophan metabolites and their conjugates.
• To investigate the urinary excretion patterns of these metabolites in bladder cancer patients.
• To explore the distribution of tryptophan metabolites and their applicability in medicine analysis.

Main Methods:

• Fluorometric assay development for 3-hydroxykynurenine and 3-hydroxyanthranilic acid.
• Assay development for glucuronide and sulfate conjugates of 3-hydroxyanthranilic acid.
• Development of a sensitive fluorescence reaction with UV irradiation for various tryptophan metabolites and pharmaceuticals.

Main Results:

• Increased excretion of 3-hydroxyanthranilic acid was observed in bladder cancer patients.
• Minor excretion of conjugated forms (glucuronide and sulfate) of 3-hydroxyanthranilic acid was noted in humans.
• Data suggests 3-hydroxykynurenine may have an affinity for the pancreas.
• A sensitive UV-activated fluorescence method was established for kynurenic acid, kynurenine, nicotinamide, and quinolinic acid.
• The method was successfully applied to determine drug concentrations in serum and urine.

Conclusions:

• The developed fluorometric assays are valuable tools for studying tryptophan metabolism in relation to bladder cancer.
• Altered excretion of specific metabolites may serve as potential biomarkers for bladder cancer.
• The sensitive fluorescence method has broad applicability for analyzing tryptophan metabolites and various pharmaceutical compounds.